BRENDA OLMOS: Open Payments
NPI 1811410392 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,114 in 26 payments from 15 companies in 2025. Trend: 2023 $2,133 · 2024 $1,988 · 2025 $3,114
Food & beverage: $2,134Speaker / faculty: $963Travel & lodging: $18
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 6 | $1,167 |
| AstraZeneca Pharmaceuticals LP | 3 | $375 |
| GENZYME CORPORATION | 2 | $242 |
| Gilead Sciences, Inc. | 2 | $234 |
| Phathom Pharmaceuticals, Inc. | 2 | $230 |
| Inspire Medical Systems, Inc. | 1 | $143 |
| Amgen Inc. | 1 | $132 |
| Boston Scientific Corporation | 1 | $124 |
| Sandoz Inc. | 1 | $112 |
| Amarin Pharma, Inc. | 1 | $103 |
Products named: Korlym, VOQUEZNA, INSPIRE, REPATHA, WATCHMAN FLX, FLUMIST QUADRIVALENT, Livdelzi, Vascepa.
Industry payments across TX — which companies pay providers there.
